Post-market surveillance and vigilance
Manufacturer is required to submit vigilance reports to the ANSM for any incidents occurred in France involving in vitro diagnostic medical devices, in accordance with Regulation (EU) 2017/746.The manufacturer must also take appropriate safety action when required.
Further information about reporting adverse incidents and corrective actions to ANSM is available for manufacturers of in vitro diagnostic medical devices.
We encourage manufacturers to use European Medical Device Nomenclature (EMDN).
Manufacturer Incident Report (MIR)
- Manufacturers should notify the ANSM of MIR using the MIR Manufacturer Incident Report (MIR) form.
- Manufacturers should sent MIR (pdf and xml format) by mailbox: reactovigilance@ansm.sante.fr.
- To monitor the registration of MIR, manufacturers have an access via Vigimater to put ANSM’s reference.
Field Safety Corrective Actions (FSCAs)
- Manufacturers should notify the ANSM of FSCA using the FSCA Report Form.
- Manufacturers should sent FSCA by mailbox: reactovigilance@ansm.sante.fr.
Trend report
- Manufacturers should notify the ANSM of trend report using the Manufacturer’s Trend Report Form.
- Manufacturers should sent Trend Report by mailbox: reactovigilance@ansm.sante.fr.
Periodic Summary Report (PSR)
- Manufacturers should notify the ANSM of Periodic Summary Report using the Manufacturer’s PSR Report Form.
- Manufacturers should sent PSR by mailbox: reactovigilance@ansm.sante.fr.